Dana Farber Drug Success: EXAMPLE! While a trial

Dana Farber Drug Success: EXAMPLE!

While a trial at Dana Farber, by no means implies impending achievements or drug approval by the Food and Drug Administration, some major drugs have come through the cancer center and have led to great successes for companies. Millenium Pharmaceuticals researched bortezomib (Velcade®) at Dana-Farber as an indication for multiple myeloma. Velcade® received FDA clearance in only seven years after initial synthesis even with early-stage trials moving notably slow as the drug moved through three different companies at first. Millenium was bought by Takeda Pharmaceutical Company (TSE:4502) in April 2008 for nearly $9 billion with Velcade® as its flagship product which is still undergoing research at Dana-Farber for different indications.